Humanized antibodies against TL1A
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 11, 2012
Grant Date -
Nov 12, 2009
app pub date -
Nov 13, 2008
filing date -
Nov 13, 2007
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Disclosed are humanized antibodies that bind specifically to the receptor TNF superfamily member 15 (TNFSF15), also known as TL1A. Methods of making and using the anti-TL1A antibodies are also described. The humanized antibodies may be antagonists and may used to treat or diagnose conditions associated with TL1A function.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully